Pivot Initiates Development of Its First Cannabidiol Product with German Technology Partner
Dec 29, 2017 13:05 pm UTC| Business
VANCOUVER, British Columbia, Dec. 29, 2017 -- via NetworkNewsWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that it has commenced development of PGS-N001...
InterCloud Systems’ Netlayer.io Software Platform Becomes a Computer Associates Technology Partner
Dec 29, 2017 13:00 pm UTC| Business
SHREWSBURY, N.J., Dec. 29, 2017 -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (OTC:ICLD), a leading provider of cloud networking orchestration and automation solutions and services, today announced that...
Graphite One Resources Appoints Taiga Mining Executives to Advisory Board, Awards Options
Dec 29, 2017 13:00 pm UTC| Business
VANCOUVER, British Columbia, Dec. 29, 2017 -- Graphite One Resources Inc. (TSX-V:GPH) (OTCQB:GPHOF) (“Graphite One” or the “Company”) Graphite One Resources announced today the appointment to its Advisory Board of Kevin...
Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 29, 2017 13:00 pm UTC| Business
BOSTON, Dec. 29, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant to two employees of inducement stock...
Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 29, 2017 13:00 pm UTC| Business
DANVERS, Mass., Dec. 29, 2017 -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will...
Kforce Inc. Announced Estimated Impact of New U.S. Tax Law on Fourth Quarter 2017 Guidance
Dec 29, 2017 12:31 pm UTC| Business
TAMPA, Fla., Dec. 29, 2017 -- Kforce Inc. (NASDAQ:KFRC) today announced that it expects to record a one-time, non-cash charge in the fourth quarter of 2017 as a result of the recently enacted Tax Cuts and Jobs Act...
Avadel Pharmaceuticals Issues 2018 Corporate Outlook
Dec 29, 2017 12:30 pm UTC| Business
Commercial launch for Noctiva™ on target for second quarter 2018 NDA filing for FT218 expected by year-end 2018 Total revenues expected to range from $110 - 130 million DUBLIN, Ireland, Dec. 29, 2017 -- Avadel...